EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Transcenta Holding's enterprise value is HK$629.55 Mil.
Transcenta Holding's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$58.90 Mil. Therefore, Transcenta Holding's EV-to-Revenue for today is 10.69.
The historical rank and industry rank for Transcenta Holding's EV-to-Revenue or its related term are showing as below:
HKSE:06628'
s EV-to-Revenue Range Over the Past 10 Years
Min: -8.41 Med: 8.91 Max: 67.32
Current: 10.69
During the past 5 years, the highest EV-to-Revenue of Transcenta Holding was 67.32. The lowest was -8.41. And the median was 8.91.
HKSE:06628's EV-to-Revenue is ranked worse than 56.36% of 1038
companies
in the Biotechnology industry
Industry Median: 8.075
vs HKSE:06628: 10.69
The historical data trend for Transcenta Holding's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Transcenta Holding's EV-to-Revenue
For the Biotechnology subindustry, Transcenta Holding's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Transcenta Holding's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Transcenta Holding's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Transcenta Holding's EV-to-Revenue falls into.
Transcenta Holding's current Enterprise Value is HK$629.55 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Transcenta Holding's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$58.90 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Transcenta Holding's share price for today is HK$1.76.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.15.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Transcenta Holding EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Transcenta Holding's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Transcenta Holding (HKSE:06628) Business Description
Transcenta Holding Ltd is a clinical stage biopharmaceutical company with fully integrated capacities in discovery, research, development and manufacturing. It is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Geographically the company operates in China (the "PRC") and the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06628 has been successfully added to your 